Poccia Claudia
Known title: DirectorCIK: 0001783881
Associated companies
Transaction History
| IOSP | ▼ Sell | Open Market | 119 | $9K | 2/27/2026 | View on chart |
| IOSP | ▲ Buy | Grant | 1,539 | $0 | 2/23/2026 | View on chart |
| IOSP | ▲ Buy | Grant | 1,209 | $0 | 2/24/2025 | View on chart |
| IOSP | ▲ Buy | Option Exercise | 300 | $30K | 11/22/2024 | View on chart |
| IOSP | ▼ Sell | Open Market | 300 | $36K | 11/22/2024 | View on chart |
| IOSP | ▲ Buy | Grant | 782 | $0 | 2/26/2024 | View on chart |
| IOSP | ▲ Buy | Option Exercise | 424 | $30K | 8/11/2023 | View on chart |
| IOSP | ▼ Sell | Tax Withholding | 283 | $31K | 8/11/2023 | View on chart |
| IOSP | ▲ Buy | Option Exercise | 1,000 | $0 | 5/22/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 400 | $40K | 5/22/2023 | View on chart |
| IOSP | ▲ Buy | Option Exercise | 848 | $0 | 5/22/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 339 | $34K | 5/22/2023 | View on chart |
| IOSP | ▲ Buy | Grant | 594 | $0 | 2/27/2023 | View on chart |
| IOSP | ▲ Buy | Grant | 652 | $0 | 2/21/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Innospec schedules Q3 2026 earnings release and call
Innospec has announced the date for its third-quarter 2026 earnings release and conference call. The company recently completed its Q2 2026 earnings call, providing the latest update on its performance. This upcoming event will likely offer further insight into the firm's operational outlook.
Innospec schedules Q3 2026 earnings release and call. Innospec has announced the date for its third-quarter 2026 earnings release and conference call. The company recently completed its Q2 2026 earnings call, providing the latest update on its performance. This upcoming event will likely offer further insight into the firm's operational outlook.